Search Login Register

troglitazone (Rezulin) Summary

Description: induces solid tumor differentiation; structure given in first source; withdrawn from the market by manufacturer; PPAR agonist used for type II diabetes

Also Known As: Rezulin; Prelay; 5-(4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione); CS 045; CS-045 Show All >>

Networked: 743 relevant articles (86 outcomes, 157 trials/studies) for this Drug

Key Diseases for which troglitazone is Relevant

  1. Insulin Resistance : 22 outcomes 16 studies in 136 results
  2. Type 2 Diabetes Mellitus (MODY) : 13 outcomes 27 studies in 109 results
  3. Hyperinsulinism (Hyperinsulinemia) : 9 outcomes 3 studies in 32 results
  4. Hyperglycemia : 8 outcomes 1 study in 29 results
  5. Hypertension (High Blood Pressure) : 4 outcomes 3 studies in 15 results
Show All >>

Drugs Related to troglitazone

  1. Insulin (Novolin)
  2. Glucose (Dextrose)
  3. PPAR gamma
  4. Metformin (Glucophage)
  5. Thiazolidinediones
  6. pioglitazone (Actos)
  7. Peroxisome Proliferator-Activated Receptors (PPAR)
  8. 2,4-thiazolidinedione (thiazolidinedione)
  9. rosiglitazone (Avandia)
  10. Acarbose
Show All >>

Therapies Related to troglitazone

  1. Oral Administration
  2. Heterologous Transplantation (Xenotransplantation)
  3. Injections
  4. Amputation
  5. Stents
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.